I have never come across a FDA approval is just a formality
- Forums
- ASX - By Stock
- CYC
- Ann: Technegas USA Trial Successfully Meets Primary Endpoint
CYC
cyclopharm limited
Add to My Watchlist
5.26%
!
90.0¢

Ann: Technegas USA Trial Successfully Meets Primary Endpoint, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
90.0¢ |
Change
-0.050(5.26%) |
Mkt cap ! $100.0M |
Open | High | Low | Value | Volume |
95.0¢ | 97.0¢ | 90.0¢ | $63.16K | 68.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 8620 | 89.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
91.0¢ | 3000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8620 | 0.895 |
3 | 6643 | 0.890 |
1 | 2000 | 0.885 |
4 | 10543 | 0.880 |
1 | 5000 | 0.875 |
Price($) | Vol. | No. |
---|---|---|
0.910 | 3000 | 1 |
0.915 | 9000 | 1 |
0.920 | 19117 | 3 |
0.930 | 543 | 1 |
0.945 | 210 | 1 |
Last trade - 12.01pm 26/06/2025 (20 minute delay) ? |
Featured News
CYC (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online